High dosage of Prostate-Specific Antigen (PSA) in a patient after radical prostatectomy and without clinical evidence to support tumor recurrence: case report. Research, Society and Development, [S. l.], v. 10, n. 13, p. e93101321104, 2021. DOI: 10.33448/rsd-v10i13.21104. Disponível em: https://rsdjournal.org/rsd/article/view/21104. Acesso em: 5 dec. 2025.